[Evaluation of 99mTc-HM-PAO thigh accumulation in patients with cerebro-vascular disease]

Kaku Igaku. 1993 Jun;30(6):593-603.
[Article in Japanese]

Abstract

99mTc-HM-PAO cerebral SPECT and whole body scintigraphy (WBS) were performed in 5 patients without cerebro-vascular disease (CVD) (Group 1), 31 patients with CVD but not hemiparesis (Group 2) and 18 patients with CVD and hemiparesis (Group 3). Four ROIs were drawn manually around the whole body (WB), brain (Br), right and left thigh (Th). We calculated some ratios: the total counts in the brain over the total counts in the whole body (Br/WB), the total counts in the thigh over the total counts in the whole body (Th/WB) and the mean counts in the thigh over the mean counts in the brain (Th/Br). The Br/WB was 6.9 +/- 1.8%, rt-Th/WB was 4.9 +/- 2.1%, lt-Th/WB was 5.1 +/- 1.3% and Th/Br was 0.46 +/- 0.17 in group 1. Whole body scintigraphies in group 1 revealed clear and similar images between right and left thigh. The Br/WB was 6.7 +/- 1.4%, Th/WB of paretic side was 4.6 +/- 1.0%, Th/WB of non-paretic side was 5.8 +/- 1.2% and Th/Br was 0.47 +/- 0.18 in group 3. The Th/WB in non paretic side was significantly higher than that in paretic side (p < 0.01). The thigh images in group 3 revealed clearly different between paretic and non-paretic thigh. In conclusion we could acquire the clear thigh images with 99mTc-HM-PAO. It was possible that we evaluated not only cerebral perfusion but also muscle atrophy and/or perfusion in patients with CVD using 99mTC-HM-PAO.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Cerebrovascular Disorders / diagnostic imaging*
  • Cerebrovascular Disorders / physiopathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organotechnetium Compounds*
  • Oximes*
  • Regional Blood Flow
  • Technetium Tc 99m Exametazime
  • Thigh / blood supply
  • Thigh / diagnostic imaging*
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Organotechnetium Compounds
  • Oximes
  • Technetium Tc 99m Exametazime